ScreenerHero

XBITXBiotech Inc.

NAS · US · Healthcare · Biotechnology · xbiotech.com
2.280USD-1.30%Mkt Cap: 69.51M $P/E: —

XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious dise…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap69.51M $
Enterprise Value-39.10M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-45.54M $
Revenue/Share—
Last Price2.280 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees85
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINCA98400H1029
Valuation
P/E (Trailing)—
P/E (Forward)17.77
PEG—
EV/EBITDA0.84
EV/Revenue—
P/S—
P/B0.55
EPS (TTM)-1.46
EPS (Forward)0.13
52W Range
2.09012% of range3.610
52W High3.610 USD
52W Low2.090 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-32.45%
ROA-30.34%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-39.92M $
CapEx (TTM)289.00K $
FCF Margin—
FCF Yield-36.55%
Net Debt-109.53M $
Net Debt/EBITDA2.34
Balance Sheet
Debt/Equity—
Current Ratio33.15
Quick Ratio32.75
Book Value/Sh4.214 USD
Cash/Share3.593 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJul 15, 2021
Pay DateJul 23, 2021
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.30.49M
Float22.84M
Insiders24.33%
Institutions6.73%
Short Interest
Short Ratio8.0d
Short % Float1.25%
Short % Out.1.07%
Shares Short325.40K
Short (prev mo.)275.57K
Technical
SMA 502.304 (-1.1%)
SMA 2002.398 (-4.9%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)35.21K
Avg Vol (10d)30.16K
Technical Indicators
RSI (14)47.4
MACD0.0037
MACD Signal-0.0008
MACD Hist.+0.0045
BB Upper2.386 USD
BB Middle2.284 USD
BB Lower2.183 USD
BB Width8.89%
ATR (14)0.0643 USD
Vol Ratio (20d)0.36x